GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zealand Pharma AS (OCSE:ZEAL) » Definitions » Cyclically Adjusted FCF per Share

Zealand Pharma AS (OCSE:ZEAL) Cyclically Adjusted FCF per Share : kr-15.28 (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Zealand Pharma AS Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Zealand Pharma AS's adjusted free cash flow per share for the three months ended in Dec. 2024 was kr-2.594. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr-15.28 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -13.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -21.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Zealand Pharma AS was -13.20% per year. The lowest was -32.60% per year. And the median was -23.00% per year.

As of today (2025-05-12), Zealand Pharma AS's current stock price is kr428.80. Zealand Pharma AS's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2024 was kr-15.28. Zealand Pharma AS's Cyclically Adjusted Price-to-FCF of today is .


Zealand Pharma AS Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Zealand Pharma AS's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zealand Pharma AS Cyclically Adjusted FCF per Share Chart

Zealand Pharma AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.44 -10.53 -13.86 -13.85 -15.28

Zealand Pharma AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.85 -14.61 -14.72 -15.22 -15.28

Competitive Comparison of Zealand Pharma AS's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Zealand Pharma AS's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zealand Pharma AS's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zealand Pharma AS's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zealand Pharma AS's Cyclically Adjusted Price-to-FCF falls into.


;
;

Zealand Pharma AS Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zealand Pharma AS's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-2.594/118.9000*118.9000
=-2.594

Current CPI (Dec. 2024) = 118.9000.

Zealand Pharma AS Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201503 -2.713 100.200 -3.219
201506 -2.525 100.300 -2.993
201509 -2.700 100.200 -3.204
201512 -1.973 99.800 -2.351
201603 1.732 100.200 2.055
201606 -2.693 100.600 -3.183
201609 -1.933 100.200 -2.294
201612 4.224 100.300 5.007
201703 -2.053 101.200 -2.412
201706 -4.820 101.200 -5.663
201709 0.013 101.800 0.015
201712 -3.411 101.300 -4.004
201803 -3.043 101.700 -3.558
201806 -3.734 102.300 -4.340
201809 -3.459 102.400 -4.016
201812 -4.926 102.100 -5.737
201903 1.575 102.900 1.820
201906 -4.415 102.900 -5.101
201909 -5.007 102.900 -5.786
201912 -4.850 102.900 -5.604
202003 -5.983 103.300 -6.887
202006 -3.010 103.200 -3.468
202009 -2.853 103.500 -3.278
202012 -6.721 103.400 -7.729
202103 -8.840 104.300 -10.077
202106 -7.568 105.000 -8.570
202109 -4.879 105.800 -5.483
202112 -7.502 106.600 -8.368
202203 -7.427 109.900 -8.035
202206 -5.151 113.600 -5.391
202209 -2.734 116.400 -2.793
202212 -5.467 115.900 -5.609
202303 -3.841 117.300 -3.893
202306 -3.071 116.400 -3.137
202309 -2.030 117.400 -2.056
202312 0.842 116.700 0.858
202403 -3.687 118.400 -3.703
202406 -3.787 118.500 -3.800
202409 -4.187 118.900 -4.187
202412 -2.594 118.900 -2.594

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Zealand Pharma AS  (OCSE:ZEAL) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Zealand Pharma AS Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Zealand Pharma AS's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Zealand Pharma AS Business Description

Industry
Traded in Other Exchanges
Address
Sydmarken 11, Soborg, DNK, DK-2860
Zealand Pharma AS is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. The company's product pipeline includes three product candidates in clinical development: glepaglutide, which is being developed to treat short bowel syndrome or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The company has out-licensed a peptide program to Boehringer Ingelheim that has been moved ahead into early clinical development: a once-weekly novel dual-acting GLP-1/glucagon agonist for the treatment of obesity and/or Type 2 diabetes.